000			02079 a2200625 4500
005			20250516205345.0
264		0	_c20140714
008			201407s 0 0 eng d
022			_a1524-4571
024	7		_a10.1161/CIRCRESAHA.114.303200 _2doi
040			_aNLM _beng _cNLM
100	1		_aDuran, Jason M
245	0	0	_aSorafenib cardiotoxicity increases mortality after myocardial infarction. _h[electronic resource]
260			_bCirculation research _cMay 2014
300			_a1700-1712 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCats
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aHeart _xdrug effects
650	0	4	_aIn Vitro Techniques
650	0	4	_aMale
650	0	4	_aMetoprolol _xpharmacology
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMyocardial Infarction _xmortality
650	0	4	_aMyocytes, Cardiac _xdrug effects
650	0	4	_aNiacinamide _xadverse effects
650	0	4	_aPhenylurea Compounds _xadverse effects
650	0	4	_aProto-Oncogene Proteins c-kit _xdrug effects
650	0	4	_aSorafenib
700	1		_aMakarewich, Catherine A
700	1		_aTrappanese, Danielle
700	1		_aGross, Polina
700	1		_aHusain, Sharmeen
700	1		_aDunn, Jonathan
700	1		_aLal, Hind
700	1		_aSharp, Thomas E
700	1		_aStarosta, Timothy
700	1		_aVagnozzi, Ronald J
700	1		_aBerretta, Remus M
700	1		_aBarbe, Mary
700	1		_aYu, Daohai
700	1		_aGao, Erhe
700	1		_aKubo, Hajime
700	1		_aForce, Thomas
700	1		_aHouser, Steven R
773	0		_tCirculation research _gvol. 114 _gno. 11 _gp. 1700-1712
856	4	0	_uhttps://doi.org/10.1161/CIRCRESAHA.114.303200 _zAvailable from publisher's website
999			_c23723913 _d23723913